MedPath

RDD PHARMA LTD

RDD PHARMA LTD logo
🇮🇱Israel
Ownership
-
Employees
-
Market Cap
-
Website

Clinical Trials

11

Active:0
Completed:6

Trial Phases

2 Phases

Phase 1:8
Phase 2:3

Drug Approvals

0

Drug Approvals

No drug approvals found

This company may not have drug approvals in our database

Clinical Trials

Distribution across different clinical trial phases (11 trials with phase data)• Click on a phase to view related trials

Phase 1
8 (72.7%)
Phase 2
3 (27.3%)

RDD1609 as a Treatment for Idiopathic Pruritus Ani

Phase 2
Withdrawn
Conditions
Idiopathic Pruritus Ani
Interventions
First Posted Date
2018-11-28
Last Posted Date
2022-11-03
Lead Sponsor
RDD Pharma Ltd
Registration Number
NCT03757403
Locations
🇬🇧

The Atherstone Surgery, Atherstone, United Kingdom

🇬🇧

University Hospitals Bristol NHS Foundation Trust- Location Bristol Royal Infirmary, Bristol, United Kingdom

🇬🇧

Kings Medical Centre, Buckhurst Hill, United Kingdom

and more 1 locations

Intra-anal Oxymetazoline in Healthy Adult Volunteers

Phase 1
Conditions
Fecal Incontinence
Interventions
First Posted Date
2018-05-18
Last Posted Date
2022-08-02
Lead Sponsor
RDD Pharma Ltd
Target Recruit Count
40
Registration Number
NCT03529487
Locations
🇺🇸

Spaulding Clinical Research, LLC, West Bend, Wisconsin, United States

The Effect of Intra-anal Nifedipine, Used As Add-on to Conservative Therapy, on Pain in Patients With Anal Fissure

Phase 2
Completed
Conditions
Chronic Anal Fissure
Interventions
First Posted Date
2015-08-18
Last Posted Date
2018-10-23
Lead Sponsor
RDD Pharma Ltd
Target Recruit Count
339
Registration Number
NCT02527109
Locations
🇧🇬

UMHAT "Sveti Georgi", Internal Consulting Department, Plovdiv, Bulgaria

🇧🇬

"Multiprofile Hospital for Active Treatment - Doverie" AD, Clinic of Gastroenterology, Sofia, Bulgaria

🇧🇬

II MHAT, Internal Clinic, Department of Gastroenterology, Sofia, Bulgaria

and more 21 locations

The Effect of Oxymetazoline Gel on Anal Pressure and Incontinence in Spinal Cord Injury Patients

Phase 1
Completed
Conditions
Spinal Cord Injury
Fecal Incontinence
Interventions
Drug: Placebo gel
First Posted Date
2014-11-24
Last Posted Date
2015-07-28
Lead Sponsor
RDD Pharma Ltd
Target Recruit Count
19
Registration Number
NCT02299557
Locations
🇭🇺

Semmelweis Egyetem I. sz. Belgyógyászati Klinika, Budapest, Hungary

An Open Label Multi-Dose Study to Examine the Effect of Coated Nifedipine Suppository on Anal Fissure Pain and Healing

Phase 1
Terminated
Conditions
Anal Fissure
Interventions
First Posted Date
2013-12-30
Last Posted Date
2015-11-17
Lead Sponsor
RDD Pharma Ltd
Target Recruit Count
33
Registration Number
NCT02023047
Locations
🇮🇱

Macabi outpatient clinic, Rehovot, Israel

🇮🇱

Macabi HMO outpatient clinic, Tel Aviv, Israel

🇮🇱

Asaf Harofe Hospital, Zrifin, Israel

  • Prev
  • 1
  • 2
  • 3
  • Next

News

No news found

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.